Aqtual
Hayward
About Aqtual
Aqtual is a biotechnology diagnostics platform that provides healthcare solutions, novel technology, and biochemistry for chronic disease. The company utilizes a novel cell-free DNA-based platform that evaluates protein regulation, epigenetics, and transcriptomics solely using cell-free DNA fragments found in the blood. The platform also yields efficient and robust real-time analysis of disease and treatment while overcoming the limitations of previous cell-free DNA methodologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $47.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2025)
- Website: aqtual.com
- Phone: +1 341 208 8569
Industries & Categories
Biotechnology, Health Care, Machine Learning, Wellness
Social Profiles
Canonical: https://fsome.com/organization/aqtual-99470 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.